These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12447110)

  • 1. Will improved understanding of the pathophysiological mechanisms involved in acute spinal cord injury improve the potential for therapeutic intervention?
    Dumont AS; Dumont RJ; Oskouian RJ
    Curr Opin Neurol; 2002 Dec; 15(6):713-20. PubMed ID: 12447110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and pharmacologic treatment of acute spinal cord injury.
    Kwon BK; Tetzlaff W; Grauer JN; Beiner J; Vaccaro AR
    Spine J; 2004; 4(4):451-64. PubMed ID: 15246307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets for therapeutic intervention after spinal cord injury.
    Kwon BK; Borisoff JF; Tetzlaff W
    Mol Interv; 2002 Jul; 2(4):244-58. PubMed ID: 14993395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies of medical intervention in the management of acute spinal cord injury.
    Hurlbert RJ
    Spine (Phila Pa 1976); 2006 May; 31(11 Suppl):S16-21; discussion S36. PubMed ID: 16685230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoring function after spinal cord injury.
    Becker D; Sadowsky CL; McDonald JW
    Neurologist; 2003 Jan; 9(1):1-15. PubMed ID: 12801427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to restore motor functions after spinal cord injury.
    Boulenguez P; Vinay L
    Curr Opin Neurobiol; 2009 Dec; 19(6):587-600. PubMed ID: 19896827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury.
    Esposito E; Paterniti I; Mazzon E; Genovese T; Di Paola R; Galuppo M; Cuzzocrea S
    Brain Behav Immun; 2011 Aug; 25(6):1099-112. PubMed ID: 21354467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration.
    Blits B; Boer GJ; Verhaagen J
    Cell Transplant; 2002; 11(6):593-613. PubMed ID: 12428749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A select combination of neurotrophins enhances neuroprotection and functional recovery following spinal cord injury.
    Sharma HS
    Ann N Y Acad Sci; 2007 Dec; 1122():95-111. PubMed ID: 18077567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury.
    Hawryluk GW; Rowland J; Kwon BK; Fehlings MG
    Neurosurg Focus; 2008; 25(5):E14. PubMed ID: 18980474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the treatment of spinal cord injury.
    Baptiste DC; Fehlings MG
    Prog Brain Res; 2007; 161():217-33. PubMed ID: 17618980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects.
    Tator CH
    Neurochirurgie; 1991; 37(5):291-302. PubMed ID: 1758561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future therapeutic strategies for functional repair of spinal cord injury.
    Tohda C; Kuboyama T
    Pharmacol Ther; 2011 Oct; 132(1):57-71. PubMed ID: 21640756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neuroprotective role of glial cell line-derived neurotrophic factor following moderate spinal cord contusion injury.
    Iannotti C; Ping Zhang Y; Shields CB; Han Y; Burke DA; Xu XM
    Exp Neurol; 2004 Oct; 189(2):317-32. PubMed ID: 15380482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for neuroprotection following spinal cord injury.
    Tederko P; Krasuski M; Kiwerski J; Nyka I; Białoszewski D
    Ortop Traumatol Rehabil; 2009; 11(2):103-10. PubMed ID: 19502667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection after spinal cord injury: state of the science.
    Segatore M; Way C
    SCI Nurs; 1997 Mar; 14(1):8-18. PubMed ID: 9165951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoring walking after spinal cord injury.
    Fouad K; Pearson K
    Prog Neurobiol; 2004 Jun; 73(2):107-26. PubMed ID: 15201036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic dysreflexia after spinal cord injury: central mechanisms and strategies for prevention.
    Weaver LC; Marsh DR; Gris D; Brown A; Dekaban GA
    Prog Brain Res; 2006; 152():245-63. PubMed ID: 16198705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental models for spinal cord injury research: physical and physiological considerations.
    Anderson TE; Stokes BT
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S135-42. PubMed ID: 1588604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury.
    Pitzer C; Klussmann S; Krüger C; Letellier E; Plaas C; Dittgen T; Kirsch F; Stieltjes B; Weber D; Laage R; Martin-Villalba A; Schneider A
    J Neurochem; 2010 May; 113(4):930-42. PubMed ID: 20202082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.